L'apport du Cannabidiol (CBD) chez les patientes souffrant d’endométriose

dissertation OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex

Abstract

Endometriosis is a chronic inflammatory gynecological disease affecting over 200 million women of childbearing age. It affects more than 1 in 10 women worldwide. The disease is complex, and its origin has yet to be established. There are different types of endometriosis, which complicates diagnosis. Painful symptoms can be treated using anti-inflammatory drugs, analgesics and sometimes hormonal treatments. Surgery is also possible, depending on the case. Many patients who find themselves in a situation of medical wandering turn to therapeutic alternatives such as Cannabidiol (CBD). However, its use is the subject of debate in France. The aim of this thesis is to review the current state of knowledge about endometriosis and the current use of cannabidiol in the treatment of endometriotic pain. A great deal of work is being carried out on this subject. Some have analyzed the expression of cannabinoid receptors on endometriotic lesions, while other research focuses on different synthetic or natural cannabinoid receptor agonists or antagonists. Certain results may indicate an action of the endocannabinoid system on the inflammation of endometriosis or, on the contrary, a lack of efficacy compared with the treatments usually prescribed. Nevertheless, the overall picture remains too disparate to draw sufficient conclusions at this stage. To date, there are three clinical studies underway, the results of which could provide enlightening information on the use of CBD in endometriosis.
Full text 1,068 characters · extracted from oa-html · click to expand
Making sure you're not a bot! Loading... You are seeing this because the administrator of this website has set up Anubis to protect the server against the scourge of AI companies aggressively scraping websites. This can and does cause downtime for the websites, which makes their resources inaccessible for everyone. Anubis is a compromise. Anubis uses a Proof-of-Work scheme in the vein of Hashcash, a proposed proof-of-work scheme for reducing email spam. The idea is that at individual scales the additional load is ignorable, but at mass scraper levels it adds up and makes scraping much more expensive. Ultimately, this is a placeholder solution so that more time can be spent on fingerprinting and identifying headless browsers (EG: via how they do font rendering) so that the challenge proof of work page doesn't need to be presented to users that are much more likely to be legitimate. Please note that Anubis requires the use of modern JavaScript features that plugins like JShelter will disable. Please disable JShelter or other such plugins for this domain.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-05-14T06:28:48.312192+00:00
License: CC0 · commercial use OK